These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 29128108)
21. Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. Neumann ID J Neuroendocrinol; 2008 Jun; 20(6):858-65. PubMed ID: 18601710 [TBL] [Abstract][Full Text] [Related]
22. Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies. Ross S Psychiatr Clin North Am; 2012 Jun; 35(2):357-74. PubMed ID: 22640760 [TBL] [Abstract][Full Text] [Related]
23. Making a bad thing worse: adverse effects of stress on drug addiction. Cleck JN; Blendy JA J Clin Invest; 2008 Feb; 118(2):454-61. PubMed ID: 18246196 [TBL] [Abstract][Full Text] [Related]
24. Involvement of the brain histaminergic system in addiction and addiction-related behaviors: a comprehensive review with emphasis on the potential therapeutic use of histaminergic compounds in drug dependence. Brabant C; Alleva L; Quertemont E; Tirelli E Prog Neurobiol; 2010 Nov; 92(3):421-41. PubMed ID: 20638439 [TBL] [Abstract][Full Text] [Related]
25. The "rut metaphor": a conceptualization of attractor-shaping properties of addictive drugs. Zullino DF; Khazaal Y Subst Use Misuse; 2008; 43(3-4):469-79. PubMed ID: 18365944 [TBL] [Abstract][Full Text] [Related]
26. Pharmacotherapy of addictive disorders. Ross S; Peselow E Clin Neuropharmacol; 2009; 32(5):277-89. PubMed ID: 19834993 [TBL] [Abstract][Full Text] [Related]
27. Breaking the loop: oxytocin as a potential treatment for drug addiction. McGregor IS; Bowen MT Horm Behav; 2012 Mar; 61(3):331-9. PubMed ID: 22198308 [TBL] [Abstract][Full Text] [Related]
28. Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors. Serrano A; Parsons LH Pharmacol Ther; 2011 Dec; 132(3):215-41. PubMed ID: 21798285 [TBL] [Abstract][Full Text] [Related]
29. miRNAs and Substances Abuse: Clinical and Forensic Pathological Implications: A Systematic Review. Occhipinti C; La Russa R; Iacoponi N; Lazzari J; Costantino A; Di Fazio N; Del Duca F; Maiese A; Fineschi V Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069445 [TBL] [Abstract][Full Text] [Related]
30. Addiction, molecules and morality: disease does not obviate responsibility. Cohen PJ Am J Bioeth; 2007 Jan; 7(1):21-3. PubMed ID: 17366157 [No Abstract] [Full Text] [Related]
31. Drug addiction: the neurobiology of behaviour gone awry. Volkow ND; Li TK Nat Rev Neurosci; 2004 Dec; 5(12):963-70. PubMed ID: 15550951 [TBL] [Abstract][Full Text] [Related]
32. Biochemical Diagnosis in Substance and Non-substance Addiction. Shen W; Liu H; Xie X; Liu H; Zhou W Adv Exp Med Biol; 2017; 1010():169-202. PubMed ID: 29098673 [TBL] [Abstract][Full Text] [Related]
33. Stress, sex, and addiction: potential roles of corticotropin-releasing factor, oxytocin, and arginine-vasopressin. Bisagno V; Cadet JL Behav Pharmacol; 2014 Sep; 25(5-6):445-57. PubMed ID: 24949572 [TBL] [Abstract][Full Text] [Related]
34. Existing and Future Drugs for the Treatment of the Dark Side of Addiction. Koob GF; Mason BJ Annu Rev Pharmacol Toxicol; 2016; 56():299-322. PubMed ID: 26514207 [TBL] [Abstract][Full Text] [Related]
35. Drug Therapy. He RH; Tao R Adv Exp Med Biol; 2017; 1010():219-245. PubMed ID: 29098675 [TBL] [Abstract][Full Text] [Related]
39. The role of serotonin in drug use and addiction. Müller CP; Homberg JR Behav Brain Res; 2015 Jan; 277():146-92. PubMed ID: 24769172 [TBL] [Abstract][Full Text] [Related]
40. The addictive brain: all roads lead to dopamine. Blum K; Chen AL; Giordano J; Borsten J; Chen TJ; Hauser M; Simpatico T; Femino J; Braverman ER; Barh D J Psychoactive Drugs; 2012; 44(2):134-43. PubMed ID: 22880541 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]